Skip to main content

Month: June 2025

VREMT Presents Navitas with ‘Outstanding Technical Collaboration Award’

Navitas recognized for developing and delivering next-gen GaN and SiC technologies to support major automotive OEMs, including Volvo, ZEEKR, and SMARTVREMT Presents Navitas with ‘Outstanding Technical Collaboration Award’Navitas recognized for developing and delivering next-gen GaN and SiC technologies to support major automotive OEMs, including Volvo, ZEEKR, and SMART.TORRANCE, Calif., June 24, 2025 (GLOBE NEWSWIRE) — Navitas Semiconductor (Nasdaq: NVTS), the industry leader in next-generation GaNFast™ gallium nitride (GaN) and GeneSiC™ silicon carbide (SiC) power semiconductors, has been awarded the ‘Outstanding Technical Collaboration Award’ from VREMT Energy, a subsidiary of Geely, which specializes in new energy vehicle power batteries, electric drive systems, charging systems and energy storage systems. VREMT...

Continue reading

CVR Partners 2024 Schedule K-3 Now Available

SUGAR LAND, Texas, June 24, 2025 (GLOBE NEWSWIRE) — CVR Partners, LP (NYSE: UAN) today announced that 2024 Schedule K-3s, reflecting items of international tax relevance, are now available online. Unitholders may access the information at www.taxpackagesupport.com/cvrpartners. A limited number of investors (primarily foreign unitholders, unitholders computing a foreign tax credit on their tax return and certain corporate and/or partnership unitholders) may need the detailed information disclosed on the Schedule K-3 for their specific reporting requirements. To the extent the Schedule K-3 is applicable to a unitholder’s federal income tax return filing needs, unitholders are encouraged to review the information contained on this form and refer to the appropriate federal laws or consult with their tax advisor. CVR Partners does not...

Continue reading

Veru Reports Positive Results from Phase 2b QUALITY and Maintenance Extension Study Showing Enobosarm Significantly Reduced Body Weight Regain, Prevented Fat Regain, and Preserved Lean Mass After Semaglutide Discontinuation

–During the Maintenance Period of 12 weeks after discontinuing semaglutide (GLP-1 receptor agonist), placebo group regained 43% of body weight that was previously lost during Phase 2b QUALITY study; on average, enobosarm 3mg significantly reduced body weight regain by 46% and completely prevented fat regain compared to placebo– –The enobosarm treated groups showed up to 93% greater fat loss and 100% lean mass preservation compared to the placebo group at the end of the study– –Enobosarm monotherapy had a positive safety profile with essentially no gastrointestinal side effects during the maintenance treatment period– — Based on efficacy and safety from Phase 2b QUALITY and Maintenance Extension study: —Enobosarm 3mg will advance as the proposed oral dose for the Phase 3 clinical program– –Veru...

Continue reading

TerraZero Technologies Launches Wave of Groundbreaking Artist Activations, Introducing New Firsts in Intraverse Music Experiences

VANCOUVER, British Columbia, June 24, 2025 (GLOBE NEWSWIRE) — BIGG Digital Assets Inc. (“BIGG” or the “Company”)(TSXV: BIGG; OTCQX: BBKCF; WKN: A2PS9W), a leading innovator in the digital assets space and owner of TerraZero, Netcoins and Blockchain Intelligence Group, is pleased to announce that TerraZero Technologies’ Intraverse is redefining what it means to be an artist in the digital age. Today, the company announces a new wave of music activations across its immersive platform—each a milestone not just for the participating artists, but for the evolution of virtual experiences as a whole. The Company is seeing interest from all genres and artists. On the platform, you can find artists like FEELSOUL, a New Jersey songwriter, producer, rapper and poet. Among other unique elements, FEELSOULS’s experience has writings and musings...

Continue reading

Blink Charging Names Alex Calnan Managing Director of Europe

London, United Kingdom, June 24, 2025 (GLOBE NEWSWIRE) — Blink Charging Co. (NASDAQ: BLNK) (“Blink”), a leading global owner, operator, provider, and manufacturer of electric vehicle (EV) charging equipment and services, has announced the promotion of Alex Calnan to the role of Managing Director of Europe. Calnan, who previously served as Managing Director of the UK, will now lead Blink’s efforts throughout the continent of Europe, including the United Kingdom, Ireland, Belgium, and the Netherlands, effective July 1, 2025. He will continue to be based out of Blink’s UK headquarters in St. Albans, Hertfordshire. He will be supported by Blink’s existing European leadership team. “We are confident that Alex is the right person to lead our European business, execute our strategy and selectively expand throughout Europe. He will bring...

Continue reading

DeFi Dev Corp. and dogwifhat Unleash Validator Partnership to Help Power Solana’s Future

BOCA RATON, FL, June 24, 2025 (GLOBE NEWSWIRE) — DeFi Development Corp. (Nasdaq: DFDV) (the “Company”) the first public company with a treasury strategy built to accumulate and compound Solana (“SOL”), today announced a strategic validator partnership with the dogwifhat (WIF) community, one of the most iconic and culturally significant memecoin ecosystems on Solana. Under this partnership, DeFi Dev Corp. will operate a dedicated dogwifhat validator node on the Solana blockchain. The validator will be owned by the dogwifhat community, with DeFi Dev Corp. providing technical operations, infrastructure, and ongoing performance management. The parties will jointly promote the validator and collaborate to secure delegated stake, including through an application to the Solana Foundation Delegation Program (SFDP). “This collaboration...

Continue reading

THC Therapeutics, Inc. Announces Acquisition of Oregon and California Consortium of Cannabis Companies

Breakthrough Transaction Unites Segment Leaders into a Powerful and Flexible Player in the Legal Cannabis Industry MEDFORD, Ore., June 24, 2025 (GLOBE NEWSWIRE) — THC Therapeutics, Inc. (“THCT” or the “Company”), (OTC: THCT), a company focused on the emerging and dynamic legal and regulated cannabis industry, announced today that it has acquired all of the issued and outstanding ownership interests of The Headquarters Group, Inc. (“THG”) in an all-share transaction valued at approximately $11,000,000 (the “Transaction”) and completely satisfied through the issuance of 11,007 thousand shares of newly created Series D Preferred stock. THG, through its founders, has been operating in the cannabis industry since 2001. Under the transaction, THC Therapeutics, Inc. acquired 100% of The Headquarters Group, Inc., a holding...

Continue reading

PMGC Holdings Inc. Signs Non-Binding LOI to Acquire CNC Aerospace Manufacturer Generating $4.5 Million in Annual Revenue

Serves Multiple Tier-1 Aerospace Clients AS9100 and ISO 9001-Certified CNC ManufacturerNEWPORT BEACH, Calif., June 24, 2025 (GLOBE NEWSWIRE) — PMGC Holdings Inc. (Nasdaq: ELAB) (the “Company,” “PMGC,” “we,” or “us”), a diversified public holding company, today announced that it has entered into a non-binding Letter of Intent (“LOI”) to acquire a U.S.-based, CNC machining company specializing in manufacturing high-complexity components for the aerospace and defense sectors. About the Target Company The target company, founded in 1948 is AS9100 and ISO 9001certified CNC machining firm specializing in precision aerospace components. With over 75 years of experience, the company operates a modern facility equipped with 5-axis CNC machines, advanced CAD/CAM and ERP systems, and offers a full range of secondary services including...

Continue reading

DSS, Inc.’s Subsidiary, Impact BioMedical Inc., Announces Strategic Merger

NEW YORK, June 24, 2025 (GLOBE NEWSWIRE) — DSS, Inc. (NYSE American: DSS) (“DSS” or the “Company”), a multinational company operating across diverse industries including packaging, wealth management, and biohealth innovation, today announced that its subsidiary, Impact BioMedical Inc. (“Impact”), has entered into a definitive merger agreement (the “Merger Agreement”) with Dr. Ashleys Limited (“Dr. Ashleys”), a global pharmaceutical company. Under the terms of the agreement, Dr. Ashleys will acquire Impact through a reverse merger that will result in a newly formed combined entity (the “PubCo”) traded on the NYSE American under the name “Dr Ashleys Limited.” This strategic transaction marks an important milestone not only for Impact, but also for DSS, as it reflects a successful outcome in the overall Company strategy to unlock...

Continue reading

HEDNO Advances Grid Modernization with Itron Intelligent Edge Solution in Greece

HEDNO Leverages Itron’s AMI and MDM Solutions to Enable Real-Time Insights, Efficiency and Flexibility at the Grid Edge LIBERTY LAKE, Wash., June 24, 2025 (GLOBE NEWSWIRE) — Itron, Inc. (NASDAQ: ITRI), which is innovating new ways for utilities and cities to manage energy and water, signed a contract on May 28, 2025 with Hellenic Electricity Distribution Network Operator S.A. (HEDNO), the sole electricity Distribution System Operator in Greece and one of the largest in Europe, to lay the foundation for grid edge intelligence. Itron’s Grid Edge Intelligence portfolio will enable HEDNO to improve its customers’ experience with enhanced energy consumption insights and modernize its electric grid to advance its long-term goals, which include integrating more distributed energy resources and achieving net-zero emissions by 2050. HEDNO...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.